The role of head and neck squamous cell carcinoma cancer stem cells in tumorigenesis, metastasis, and treatment failure

Frontiers in Endocrinology

Volumn 3, Issue AUG, 2012, Pages

  Chinn, Steven B ^a   Darr, Owen A ^a   Peters, R D ^a   Prince, Mark E ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

ALDH; Cancer stem cells; CD44; Head and neck squamous cell carcinoma; Metastasis; Tumorigenesis

Indexed keywords

EID: 84874400094     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2012.00090     Document Type: Review

References (54)

1. Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., and Clarke, M. F. (2003). Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. U.S.A. 100, 3983-3988
2. Balic, M., Lin, H., Young, L., Hawes, D., Giuliano, A., McNamara, G., Datar, R. H., and Cote, R. J. (2006). Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype. Clin. Cancer Res. 12,5615-5621.
3. Bonnet, D., and Dick, J. E. (1997). Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3, 730-737.
4. Brabletz, T., Jung, A., Spaderna, S., Hlubek, F., and Kirchner, T. (2005). Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression. Nat. Rev. Cancer 5, 744-749.
5. Burkert, J., Otto, W. R., and Wright, N. A. (2008). Side populations of gastrointestinal cancers are not enriched in stem cells. J. Pathol. 214, 564-573.
6. Campos, M. S., Neiva, K. G., Meyers, K. A., Krishnamurthy S., and Nör, J. E. (2012). Endothelial derived factors inhibit anoikis of head and neck cancer stem cells. Oral Oncol. 48, 26-32.
7. Chen, C., Wei, Y., Hummel, M., Hoffmann, T. K., Gross, M., Kaufmann, A. M., and Albers, A. E. (2011). Evidence for epithelial-mesenchymal transition in cancer stem cells of head and neck squamous cell carcinoma. PLoS ONE 6, e16466. doi: 10.1371/journal.pone.00 16466
8. Chen, Y.-C., Chen, Y.-W., Hsu, H.-S., Tseng, L.-M., Huang, P.-I., Lu, K.-H., Chen, D.-T., Tai, L.-K., Yung, M.-C., Chang, S.-C., Ku, H. H., Chiou, S. H., and Lo, W L. (2009). Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer. Biochem. Biophys. Res. Commun. 385, 307-313.
9. Chikamatsu, K., Ishii, H., Taka-hashi, G., Okamoto, A., Moriyama, M., Sakakura, K., and Masuyama, K. (2012). Resistance to apoptosis-inducing stimuli in CD44+ head and neck squamous cell carcinoma cells. Head Neck 34, 336-343.
10. Clarke, M. F., Dick, J. E., Dirks, P. B., Eaves, C. J., Jamieson, C. H. M., Jones, D. L., Visvader, J., Weissman, I. L., and Wahl, G. M. (2006). Cancer stem cells - perspectives on current status and future directions: AACR work shop on cancer stem cells. Cancer Res. 66, 9339-9344.
11. Clay, M. R., Tabor, M., Owen, J. H., Carey, T. E., Bradford, C. R., Wolf, G. T., Wicha, M. S., and Prince, M. E. (2010). Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase. Head Neck 32,1195-1201.
12. Davis, S. J., Divi, V., Owen, J. H., Bradford, C. R., Carey, T. E., Papagerakis, S., and Prince, M. E. P. (2010). Metastatic potential of cancer stem cells in head and neck squamous cell carcinoma. Arch. Otolaryngol. Head Neck Surg. 136, 1260-1266.
13. Dylla, S. J., Beviglia, L., Park, I. K., Chartier, C., Raval, J., Ngan, L., Pickell, K., Aguilar, J., Lazetic, S., and Smith-Berdan, S. (2008). Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy. PLoS ONE 3, e2428. doi: 10.1371/journal.pone. 0002428
14. Faber, A., Barth, C, Hormann, K., Kassner, S., Schultz, J. D., Sommer, U., Stern-Straeter, J., Thorn, C., and Goessler, U. R. (2011). CD44 as a stem cell marker in head and neck squamous cell carcinoma. Oncol Rep. 26, 321-326.
15. Ginestier, C., Hur, M. H., Charafe-Jauffret, E., Monville, F., Dutcher, J., Brown, M., Jacquemier, J., Viens, P., Kleer, C. G., Liu, S., Schott, A., Hayes, D., Birnbaum, D., Wicha, M. S., and Dontu, G. (2007). ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1,555-567.
16. Goodell, M. A., Rosenzweig, M., Kim, H., Marks, D. F., DeMaria, M., Par-adis, G., Grupp, S. A., Sieff, C. A., Mulligan, R. C., and Johnson, R. P. (1997). Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat. Med. 3, 1337-1345.
17. Hamburger, A. W., and Salmon, S. E. (1977). Primary bioassay of human tumor stem cells. Science 197, 461-463.
18. Hermann, P. C., Huber, S. L., Herrler, T., Aicher, A., Ellwart, J. W., Guba, M., Bruns, C. J.,andHeeschen, C. (2007). Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1, 313-323.
19. Hess, D. A., Meyerrose, T. E., Wirthlin, L., Craft, T. P., Her-rbrich, P. E., Creer, M. H., and Nolta, J. A. (2004). Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity. Blood 104, 1648-1655.
20. Hirschmann-Jax, C., Foster, A. E., Wulf, G. G., Nuchtern, J. G., Jax, T. W., Gobel, U., Goodell, M. A., and Brenner, M. K. (2004). A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proc. Natl. Acad. Sci. U.S.A. 101, 14228-14233.
21. Ho, M. M., Ng, A. V., Lam, S., and Hung, J. Y. (2007). Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res. 67, 4827-4833.
22. Huang, E. H., Hynes, M. J., Zhang, T., Ginestier, C., Dontu, G., Appelman, H., Fields, J. Z., Wicha, M. S., and Boman, B. M. (2009). Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res. 69, 3382-3389.
23. Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., and Forman, D. (2011). Global cancer statistics. CA Cancer J. Clin. 61, 69-90.
24. Joshua, B., Kaplan, M. J., Doweck, I., Pai, R., Weissman, I. L., Prince, M. E., and Ailles, L. E. (2012). Frequency of cells expressing CD44, a head and neck cancer stem cell marker: correlation with tumor aggressiveness. Head Neck 34, 42-49.
25. Kang, M.-K., and Kang, S.-K. (2007). Tumorigenesis of chemotherapeutic drug-resistant cancer stem-like cells in brain glioma. Stem Cells Dev. 16, 837-847.
26. Kim, C. F.B.,Jackson, E.L.,Woolfenden, A. E., Lawrence, S., Babar, I., Vogel, S., Crowley, D., Bronson, R. T., and Jacks, T. (2005). Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121, 823-835.
27. Kondo, T., Setoguchi, T., and Taga, T. (2004). Persistence of asmallsubpop-ulation of cancer stem-like cells in the C6 glioma cell line. Proc. Natl. Acad. Sci. U.S.A. 101,781-786.
28. Koukourakis, M. I., Giatromanolaki, A., Tsakmaki, V., Danielidis, V., and Sivridis, E. (2012). Cancer stem cell phenotype relates to radio-chemotherapy outcome in locally advanced squamous cell head-neck cancer. Br. J. Cancer 106, 846-853.
29. Krishnamurthy, S., Dong, Z., Vodopy-anov, D., Imai, A., Helman, J. I., Prince, M. E., Wicha, M. S., and Nör, J. E. (2010). Endothelial cell-initiated signaling promotes the survival and self-renewal of cancer stem cells. Cancer Res. 70, 9969-9978.
30. Lapidot, T., Sirard, C., Vormoor, J., Murdoch, B., Hoang, T., Caceres-Cortes, J., Minden, M., Paterson, B., Caligiuri, M. A., and Dick, J. E. (1994). A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367, 645-648.
31. Li, C., Heidt, D. G., Dalerba, P., Burant, C. F., Zhang, L., Adsay, V., Wicha, M., Clarke, M. F., and Simeone, D. M. (2007). Identification of pancreatic cancer stem cells. Cancer Res. 67, 1030-1037.
32. Lopez, J., Poitevin, A., Mendoza-Martinez, V., Perez-Plasencia, C., and Garcia-Carranca, A. (2012). Cancer-initiating cells derived from established cervical cell lines exhibit stem-cell markers and increased radioresistance. BMC Cancer 12, 48. doi: 10.1186/1471-2407-12-48
33. Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., Campbell, L. L., Polyak, K., Brisken, C., Yang, J., and Weinberg, R. A. (2008). The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704-715.
34. Matsui, W., Huff, C. A., Wang, Q., Male-horn, M. T., Barber, J., Tanhehco, Y., Smith, B. D., Civin, C. I., and Jones, R. J. (2004). Characterization of clono-genic multiple myeloma cells. Blood 103,2332-2336.
35. O'Brien, C. A., Pollett, A., Gallinger, S., and Dick, J. E. (2007). A human colon cancer cell capable of initiating tumour growth in immuno deficient mice. Nature 445, 106-110.
36. Okamoto, A., Chikamatsu, K., Sakakura, K., Hatsushika, K., Taka-hashi, G., and Masuyama, K. (2009). Expansion and characterization of cancer stem-like cells in squamous cell carcinoma of the head and neck. Oral Oncol. 45, 633-639.
37. Pearce, D. J., Taussig, D., Simpson, C., Allen, K., Rohatiner, A. Z., Lister, T. A., and Bonnet, D. (2005). Characterization of cells with a high aldehyde dehydrogenase activity from cord blood and acute myeloid leukemia samples. Stem Cells 23, 752-760.
38. Prince, M., Sivanandan, R., Kac-zorowski, A., Wolf, G., Kaplan, M., Dalerba, P., Weissman, I., Clarke, M., and Ailles, L. (2007). Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc. Natl. Acad. Sci. U.S.A. 104,973.
39. Reya, T., Morrison, S. J., Clarke, M. E, and Weissman, I. L. (2001). Stem cells, cancer, and cancer stem cells. Nature 414, 105-111.
40. Shah, A. N., Summy, J. M., Zhang, J., Park, S. I., Parikh, N. U., and Gallick, G. E. (2007). Development and characterization of gemcitabine-resistant pancreatic tumor cells. Ann. Surg. Oncol. 14, 3629-3637.
41. Siegel, R., Ward, E., Brawley, O., and Jemal, A. (2011). Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA CancerJ. Clin. 61,212-236.
42. Singh, S. K., Clarke, I. D., Terasaki, M., Bonn, V. E., Hawkins, C., Squire, J., and Dirks, P. B. (2003). Identification of a cancer stem cell in human brain tumors. Cancer Res. 63, 5821.
43. Song, L. B., Zeng, M. S., Liao, W. T., Zhang, L., Mo, H. Y., Liu, W. L., Shao, J. Y., Wu, Q. L., Li, M. Z., Xia, Y. F., Fu, L. W., Huang, W. L., Dimri, G. P., Band, V., and Zeng, Y. X. (2006). Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells. Cancer Res. 66, 6225-6232.
44. Song, J., Chang, I., Chen, Z., Kang, M., and Wang, C. Y. (2010). Characterization of side populations in HNSCC: highly invasive, chemore-sistant and abnormal Wnt signaling. PLoS ONE 5, e1 1456. doi: 10.1371/journal.pone.0011456
45. Sun, S., and Wang, Z. (2011). Head neck squamous cell carcinoma c-Met+ cells display cancer stem cell properties and are responsible for cisplatin-resistance and metastasis. Int. J. Cancer 129,2337-2348.
46. Vermeulen, L., de Sousa e Melo, F., Richel, D. J., and Medema, J. P. (2012). The developing cancer-stem-cell model: clinical challenges and opportunities. Lancet Oncol. 13,e83-e89.
47. Vermeulen, L., Sprick, M. R., Kem-per, K., Stassi, G., and Medema, J. P. (2008). Cancer stem cells - old concepts, new insights. Cell Death Differ. 15, 947-958.
48. Vlashi, E., McBride, W H., and Pajonk, E (2009). Radiation responses of cancer stem cells. J. Cell. Biochem. 108, 339-342.
49. Wang, J., Guo, L. P., Chen, L. Z., Zeng, Y. X., and Lu, S. H. (2007). Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line. Cancer Res. 67, 3716-3724.
50. Wang, S. J., Wong, G., de Heer, A.-M., Xia, W., and Bourguignon, L. Y. W. (2009). CD44 variant isoforms in head and neck squamous cell carcinoma progression. Laryngoscope 119, 1518-1530.
51. Wicha, M. S., Liu, S., and Dontu, G. (2006). Cancer stem cells: an old idea - a paradigm shift. Cancer Res. 66, 1883-1890; discussion 1895-1896.
52. Yang, J.-P., Liu, Y., Zhong, W., Yu, D., Wen, L.-J., and Jin, C.-S. (2011). Chemoresistance of CD133+ cancer stem cells in laryngeal carcinoma. Chin. Med. J. 124, 1055-1060.
53. Zhang, P., Zhang, Y., Mao, L., Zhang, Z., and Chen, W. (2009). Side population in oral squamous cell carcinoma possesses tumor stem cell phenotypes. Cancer Lett. 277, 227-234.
54. Zhou, L. L., Wei, X. X., Cheng, L. L., Tian, J. J., and Jiang, J. J. J. (2007). CD 133, one of the markers of cancer stem cells in Hep-2 cell line. Laryngoscope 117,455-460.